Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
Stock Chart Patterns
Earnings Trading
AI Screener

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. RLYB
    4. >
  4. Valuation

Valuation

-
stocks logo
RLYB
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is RLYB Overvalued？

RLYB is now in the zone, suggesting that RLYB current forward PE ratio of -0.75 is considered compare with the five-year average of -2.77.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

RLYB Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
RLYB.O
Rallybio Corp
loss
Average P/E:
43.28%
36.46M
stocks logo
OKYO.O
OKYO Pharma Ltd
loss
Average P/E:
38.91M
stocks logo
PASG.O
Passage Bio Inc
loss
Average P/E:
36.72%
37.00M
stocks logo
CVKD.O
Cadrenal Therapeutics Inc
loss
Average P/E:
-3139.74%
35.20M
stocks logo
INKT.O
Mink Therapeutics Inc
loss
Average P/E:
69.19%
43.00M
stocks logo
OCX.O
OncoCyte Corp
loss
Average P/E:
-21.47%
36.36M

RLYB Revenue Breakdown & PS Ratio Relation

By Business
By Region
Currency:USD
Composition ()
Name
Revenue
Percentage

RLYB FAQs

Is RLYB currently overvalued based on its P/E ratio?

According to the provided data, RLYB's 5-year historical average forward P/E ratio is -2.77. RLYB forward P/E ratio is -0.75, which is categorized as Overvalued.

What is the significance of the EV/EBITDA ratio for RLYB?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

What are the key indicators to watch for RLYB's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

RLYB PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
-2.77
Current PE
-0.75
Overvalued PE
-1.08
Undervalued PE
-4.46

RLYB EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
-0.27
Current EV
0.59
Overvalued EV
0.70
Undervalued EV
-1.24

RLYB P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
55.91
Current PS
480.43
Overvalued PS
210.68
Undervalued PS
-98.85

RLYB Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
RLYB.O
Rallybio Corp
loss
Average P/E:
43.28%
36.46M
stocks logo
OKYO.O
OKYO Pharma Ltd
loss
Average P/E:
38.91M
stocks logo
PASG.O
Passage Bio Inc
loss
Average P/E:
36.72%
37.00M
stocks logo
CVKD.O
Cadrenal Therapeutics Inc
loss
Average P/E:
-3139.74%
35.20M
stocks logo
INKT.O
Mink Therapeutics Inc
loss
Average P/E:
69.19%
43.00M
stocks logo
OCX.O
OncoCyte Corp
loss
Average P/E:
-21.47%
36.36M

RLYB Revenue Breakdown & PS Ratio Relation

By Business
By Region
Currency:USD
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is RLYB undervalued？Is RLYB overvalued compared to its competitors？

RLYB FAQs

Is RLYB currently overvalued based on its P/E ratio?

According to the provided data, RLYB's 5-year historical average forward P/E ratio is -2.77. RLYB forward P/E ratio is -0.75, which is categorized as Overvalued.

What is the significance of the EV/EBITDA ratio for RLYB?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

What are the key indicators to watch for RLYB's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is RLYB undervalued？Is RLYB overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free